Skip to content

Circulating Tumor Cells in Osteosarcoma

Circulating Tumor Cells in Osteosarcoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15005925
Enrollment
Unknown
Registered
2015-01-28
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteosarcoma

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital of The Forth Military Medical Univerisity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. Ag6-30, both gender; 2. Biopsy result Osteosarcoma; 3. karnofsky score more than 60 or ECOG score less than 2; 4. Expected lifetime longer than 12 weeks; 5. No serious heart, lung, liver, kidney and other important viscera disease history; 6. Sign the informed consent; 7. Well compliance.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or breast-feeding women; 2. With other malignant tumours at the same time; 3. Serious complications; 4. Severe uncontrolled medical disease or acute infection; 5. Patients can't understand the research purpose or don't agree with the requirements; 6. Does not have legal capacity or legal capacity limited; 7. Researchers determine compliance is bad, can't strictly implement scheme; 8. Any medical history, according to the judgment may interfere with the test results or increase the risk of patients.

Design outcomes

Primary

MeasureTime frame
progression free survival;overall survival;

Countries

China

Contacts

Public ContactWang Zhen
wangzhen@fmmu.edu.cn+86 029-84775281

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026